The Commonwealth Fund's latest assessment of global healthcare systems delivers a blunt verdict: the United States operates the world's most expensive health apparatus while delivering some of its worst outcomes. Americans spend 18% of gross domestic product on medical care, nearly double what comparable nations spend, yet lag behind peers on nearly every measure that matters.
The numbers are stark. The average American healthcare expenditure reaches $12,649 per person, roughly ten times Mexico's spending. Life expectancy in the US peaked at 79 years, falling more than two years short of wealthy peer nations and ranking third from the bottom in the study group. Only Mexico and Turkey perform worse. The preventable death rate here ranks second worst among developed countries.
The Commonwealth Fund's report card examines four pillars: coverage, affordability, care delivery, and equity. The United States stumbles in each category. Roughly 27 million Americans lack any health insurance at all, making the country and Mexico alone among wealthy nations without universal coverage guarantees. Primary care physician shortages mean 100 million people, nearly a third of the population, have no regular medical home until acute illness forces them into emergency care. Black women face maternal mortality rates higher than any other wealthy nation's overall rate.
One bright spot emerges in the data. Americans who maintain relationships with regular doctors report satisfaction levels among the world's highest. Personal medicine still works. Everything around it does not.
The domestic report card, however, masks a deeper crisis unfolding overseas. For decades the United States anchored global disease defense, funding roughly 40% of international humanitarian health aid and building the surveillance networks that detect outbreaks before they spread. In roughly 13 months, the US Agency for International Development has contracted from approximately 10,000 staff to fewer than 300. The country withdrew from the World Health Organization. A Lancet analysis projects that aid cuts alone will cause 14 million additional deaths by 2030, including 4.5 million children under five.
The consequences are no longer hypothetical. An Ebola outbreak caused by the Bundibugyo strain is spreading through the Democratic Republic of the Congo and Uganda. The licensed Ebola vaccine and antibody therapies were developed against different viral species and do not apply to this outbreak. The World Health Organization declared an international health emergency on May 17. The US Centers for Disease Control and Prevention learned of the outbreak roughly one day before the broader world did. In previous crises, American disease detectives would have been embedded on the ground far earlier. As one African public health official described it, the United States has become missing in action.
Domestically, a hantavirus case linked to a cruise ship surfaced, caused by the Andes strain, the only form of this rodent-borne virus known to spread between humans. Health Secretary Robert F Kennedy Jr assured the public it was under control. The federal program designed to investigate shipborne disease outbreaks had already been gutted, with full-time staff cuts implemented a year prior.
A nation already running its healthcare system on the thinnest margins in the wealthy world cannot afford strategic retreat from infectious disease surveillance. The US operates with fewer primary care doctors and hospital beds than peer nations and a higher share of patients skipping necessary care due to cost. Simultaneous domestic contraction and global withdrawal both stem from a single calculation: a country providing minimal healthcare protection per dollar to its own citizens has dismantled the low-cost systems that protected everyone else.
Both failures deepen by design. Independent analysts project that recent and proposed federal changes will push 17 million additional Americans into the uninsured ranks by 2034, rolling back gains from the Affordable Care Act. Thousands of additional preventable deaths annually would follow. Overseas, the funding and expertise required to contain emerging threats will not materialize on a timeline matching disease spread.
These failures do not present as policy abstractions in intensive care units. They arrive as the patient rationing medication due to cost, the rural resident hours from basic care, the imported infection with no surge capacity available. Respiratory failure. Shock. Isolation protocols that delay necessary treatment. Abroad they arrive as preventable child deaths from diseases easily stopped by bed nets or antiretroviral courses. The same nation makes the same choice across both sides of a single report card. The grade is already known. The choice is to stop looking at it.
Author James Rodriguez: "We built global disease defenses precisely because domestic healthcare margins are too thin to absorb novel threats, and we are dismantling both systems simultaneously."
Comments